Markets / IPO / Symbiotec Pharmalab

Symbiotec Pharmalab IPO

Updated 20:51

Mainboard IPO on NSE and BSE · Pharmaceuticals

Status

Listed

Price band

₹938–988

Lot size

15 shares · ₹14,820

Subscribed

71.26×

How it listed

Issue price

₹988

Listing price (open)

₹988.00 0.00%

First-day close

₹1,097.70 +11.10%

Price now

₹1,513.60 +53.20%

Listing day	1 Sept 2026
Open / high / low / close	₹988.00 / ₹1,180.00 / ₹934.20 / ₹1,097.70
Shares traded on NSE	3,01,02,923
Market value at the listing-day close	₹6,886 cr

Closing prices since listing: 26 Oct ₹1,229.80, 27 Oct ₹1,277.80, 28 Oct ₹1,274.70, 29 Oct ₹1,250.20, 30 Oct ₹1,246.30, 2 Nov ₹1,225.00, 3 Nov ₹1,263.00, 4 Nov ₹1,233.20, 5 Nov ₹1,271.50, 6 Nov ₹1,525.80.

Symbiotec Pharmalab share price, live chart and technicals →

Key dates

Bidding opens	24 Aug 2026
Bidding closes	27 Aug 2026
Allotment	28 Aug 2026
Refunds and shares in demat	31 Aug 2026
Listing	1 Sept 2026

Issue reservation

Investor group	Shares	% of issue	Most applicants allotted
Anchor investors	53,25,909	28.87%	–
Institutions (QIB)	37,39,872	20.27%	–
HNI / NII	28,04,904	15.20%	–
HNI, above ₹10 lakh	18,69,936	10.13%	1,833
HNI, ₹2–10 lakh	9,34,968	5.07%	4,452
Retail	65,44,776	35.47%	4,36,318
Employees	35,377	0.19%	–

Shares NSE lists as offered to each group, plus the anchor portion. "Most applicants allotted" is how many people can get the minimum application in that group when it is oversubscribed.

Lot size by investor type

Application	Lots	Shares	Amount
Retail (minimum)	1	15	₹14,820
Retail (maximum)	13	195	₹1,92,660
Small HNI (minimum)	14	210	₹2,07,480
Small HNI (maximum)	67	1,005	₹9,92,940
Big HNI (minimum)	68	1,020	₹10,07,760

At ₹988 a share. Retail bids go up to ₹2 lakh, small HNI from ₹2 lakh to ₹10 lakh, big HNI above ₹10 lakh.

Chance of getting shares (retail)

Chance

At least 1 in 13

Retail allotments available

4,36,318 × one lot

Retail portion subscribed

12.96×

An estimate from the times the retail portion was subscribed, as if every applicant bid for the minimum. Many bid for more lots, so the real chance is usually better. Winners are picked by lottery and each gets the minimum (one lot).

Subscription

Investor category	Shares offered	Shares bid for	Times subscribed
Institutions (QIB)	37,39,872	64,33,59,195	172.03×
HNI / NII	28,04,904	20,65,35,120	73.63×
HNI, above ₹10 lakh	18,69,936	15,50,46,495	82.92×
HNI, ₹2–10 lakh	9,34,968	5,14,88,625	55.07×
Retail	65,44,776	8,48,10,330	12.96×
Employees	35,377	5,45,055	15.41×
Total	1,31,24,929	93,52,49,700	71.26×

NSE and BSE bids together, as of 27 Aug 2026 19:00.

Demand at each price

Top price ₹988	8,627.60 lakh shares	92.2%
Cut-off final price, whatever it is; mostly retail	726.91 lakh shares	7.8%
Lower prices ₹938–987	2.45 lakh shares	0.0%

Shares bid on NSE and BSE at each price in the band. Most bids at the top price, and little at lower prices, means buyers were keen.

Anchor investors

Anchor bid date	21 Aug 2026
Anchor shares	53,25,909
Raised from anchors	₹526.20 cr
Lock-in ends for the first 50% (30 days)	26 Sept 2026
Lock-in ends for the remaining 50% (90 days)	25 Nov 2026 (in 19 days)

Anchor investors are large funds that buy the day before the IPO opens. SEBI locks in half their shares for 30 days from the allotment and the rest for 90 days; they can sell from the next trading day. Traders watch these dates because extra selling can come in.

Financials and valuation

	At issue price	Now
Market value	₹6,198 cr	₹9,496 cr
P/E (last 12 months' profit)	–	–

Revenue, last 12 months	–
Profit, last 12 months	–
Return on equity	–
Debt to equity	–

From results the company filed with NSE (latest period to 30 Jun 2026). Twelve-month figures need four quarters of results, so they fill in over the first year after listing.

Other recent IPOs: Pharmaceuticals

Company	Listed	Subscribed	On listing	Since IPO
Bio Medica Laboratories SME	29 May	–	-20.00%	+4.57%
Sai Parenteral's	2 Apr	1.05×	+2.04%	+18.97%
KRM Ayurveda SME	29 Jan	–	+27.48%	+68.89%
Corona Remedies	15 Dec	137.04×	+38.42%	+129.86%
Curis Lifesciences SME	14 Nov	–	+14.14%	+38.36%
Rubicon Research	16 Oct	103.90×	+27.84%	+242.12%
Amanta Healthcare	9 Sept	82.61×	+7.14%	+54.98%
Anlon Healthcare	3 Sept	7.13×	-89.89%	-70.33%

IPO details

Price band	₹938–988
Final issue price	₹988
Lot size	15 shares
Minimum investment	₹14,820 (1 lot)
Market	NSE mainboard
Issue type	Book Building
Face value	₹2 per Equity Share
Industry	Pharmaceuticals
Issue size	₹1,757.00 crore (about 1.78 crore shares) · Fresh issue + offer for sale: fresh ₹150.00 cr, offer for sale ₹1,607.00 cr
ISIN	INE899I01028
Registrar	MUFG Intime India Private Limited Helpline: +91 810 811 4949, symbiotecpharmalab.ipo@in.mpms.mufg.com
Lead managers	JM Financial Limited, Avendus Capital Private Limited, Motilal Oswal Investment Advisors Limited and Nomura Financial Advisory and Securities (India) Private Limited
Prospectus	Red herring prospectus (NSE)

Check allotment status

Allotment was finalised on 28 Aug 2026. Check it on the registrar's page (MUFG Intime India Private Limited), NSE or BSE with your PAN or application number.

← All IPOs: open, upcoming and recently listed

From NSE's official IPO data. Expected dates follow SEBI's T+3 timetable; the exchange confirms them. Information only, not investment advice.

What is the Symbiotec Pharmalab IPO price band and lot size?

The price band is ₹938–988 per share, and one lot is 15 shares (₹14,820 at the upper price).

When is the Symbiotec Pharmalab IPO allotment date?

Allotment was finalised on 28 Aug 2026, the next working day after bidding closed on 27 Aug 2026.

How many times was the Symbiotec Pharmalab IPO subscribed?

In total 71.26 times, on NSE and BSE together; retail 12.96 times.

What is the Symbiotec Pharmalab IPO listing date?

It listed on 1 Sept 2026 on NSE and BSE.

What is the chance of getting Symbiotec Pharmalab IPO shares?

At least 1 in 13 retail applicants got the minimum lot: 4,36,318 retail allotments with the retail portion subscribed 12.96 times. Winners are picked by lottery.

When does the Symbiotec Pharmalab anchor lock-in end?

The 30-day lock-in on half of the anchor investors' shares ends on 26 Sept 2026 and the 90-day lock-in on the rest ends on 25 Nov 2026; they can sell from the next trading day.

What was the Symbiotec Pharmalab listing gain?

It opened at ₹988.00 against an issue price of ₹988, a gain of 0.00%. It is now up 53.20% from the issue price.